London: A new study by researchers at King’s College London has found that
patients with diabetes suffering from the early stages of kidney disease
have a deficiency of the protective ‘anti-ageing’ hormone, Klotho. The study, published today in
Diabetologia (the
journal of the European Association for the Study of Diabetes [EASD]),
suggests that Klotho may play a significant role in the development of
kidney disease, which is often prevalent in patients with diabetes. This could mean that Klotho levels have the potential to be used as a
risk marker to predict kidney disease, as well as being a target for
developing new treatments to prevent kidney disease in patients with
type 1 diabetes.
